Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review
CONCLUSION: AH is a severe manifestation of APS with increased mortality. Most patients developed permanent primary adrenal insufficiency, particularly those positive for anticardiolipin IgG and bilateral adrenal involvement.PMID:38244823 | DOI:10.1016/j.clim.2024.109906
Source: Clinical Immunology - Category: Allergy & Immunology Authors: Jos é A Meade-Aguilar Gabriel Figueroa-Parra Jeffrey X Yang Hannah E Langenfeld Mariana Gonz ález-Treviño Prerna Dogra Irina Bancos Michael R Moynagh M Hassan Murad Larry J Prokop Andrew C Hanson Cynthia S Crowson Al í Duarte-García Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Allergy & Immunology | Antiphospholipid Syndrome | Hemorrhagic Stroke | Hughes Syndrome | Laboratory Medicine | Pain | Stroke | Study